Robert Chung

Partner, New York



Robert advises clients on matters relating to mergers and acquisitions. He has represented numerous national and international clients, guiding them through the different phases of significant transactions, so they can realize their strategic and investment-related ambitions.

Robert has represented acquirers, targets, boards of directors, special committees and investment banks across a variety of transactions. Committed to achieving the best possible outcome for his clients, his extensive experience and knowledge enable him to navigate a wide range of complex deals, whether domestic or cross-border, negotiated or unsolicited, public or private.

Robert has experience on several high-profile billion dollar transactions, including Zimmer Holdings, Inc.'s US$13.35 billion acquisition of LVB Acquisition, Inc. and Omnicare, Inc. in its US$12.7 billion sale to CVS Health Corporation. He also represented MetLife, Inc. in its US$16.2 billion acquisition of American Life Insurance Company. His experience extends across several industry sectors including the entertainment, retail, insurance, energy, technology, healthcare and pharmaceutical industries.

Robert is a partner in the Mergers & Acquisitions Group, a global practice focusing on effective deal execution and optimized efficiency for clients across a variety of large and complex transactions.

Bars and Courts
California State Bar
New York State Bar
District of Columbia Bar
US District Court for the Central District of California
Appellate Division, First Judicial Department, New York
Northwestern University School of Law
Brown University


Recent matters include the representation of:

  • A consortium composed of Brookfield Infrastructure, its institutional partners and GIC, Singapore's sovereign wealth fund, on the US$8.4 billion acquisition of Genesee & Wyoming Inc. (NYSE:GWR), a freight railroad owner and operator based in the United States;
  • LifePoint Health, Inc. (NASDAQ: LPNT) in its US$5.6 billion merger with RCCH HealthCare Partners, which is owned by certain funds managed by affiliates of Apollo Global Management, LLC (NYSE: APO);
  • Newmont Mining Corporation (NYSE: NEM) in its US$10 billion acquisition of Goldcorp Inc. (NYSE: GG, TSX: G);
  • SodaStream International Ltd., a leading manufacturer and distributor of sparkling water makers, in its US$3.2 billion sale to PepsiCo, Inc. (NASDAQ: PEP);
  • Luxoft Holding, Inc. (NYSE: LXFT), a global technology services and consulting company based in the British Virgin Islands, in its US$2 billion sale to DXC Technology (NYSE: DXC), the world's leading independent, end-to-end IT services company;
  • Roark Capital Group and its portfolio company Arby's Restaurant Group, in Arby's US$2.9 billion acquisition of Buffalo Wild Wings, Inc. (NASDAQ: BWLD);
  • Inspire Brands, Inc., a portfolio company of Roark Capital Group, in its US$2.3 billion acquisition of Sonic Corp. (NASDAQ: SONC);
  • Calpine Corporation in its US$17 billion sale to Energy Capital Partners, an energy-focused private equity firm, and a consortium of investors including Access Industries and Canadian Pension Plan Investment Board;
  • Zimmer Holding's, Inc. in its acquisition of LVB Acquisition, Inc.;
  • Zimmer Biomet, in its acquisition of LDR Holding Corporation;
  • Omnicare, Inc., in its sale to CVS Health Corporation;
  • Illumina, Inc. in its defense against Roche Holding Ltd.'s unsolicited cash tender offer and proxy contest;
  • Omnicare, Inc. in its unsolicited cash tender offer for PharMerica Corporation;
  • Sony/ATV and EMI Music Publishing in the sale of selected music catalogs, including catalogs owned by Virgin Music Publishing Companies and Famous UK Music Publishing, to BMG, the world's fourth-largest music publishing company;
  • MetLife, Inc. in its acquisition of American Life Insurance Company and certain subsequent divestitures of businesses of American Life Insurance Company;
  • Alimentation Couche-Tard Inc. in its unsolicited cash tender offer for Casey's General Stores, Inc;
  • Applied Materials, Inc. in its acquisition of Semitool, Inc;
  • Nordic Capital, DLJ Merchant Banking, Avista Capital and other private equity sponsors in their sale of Fougera Pharmaceuticals to Sandoz;
  • First Advantage Corporation in the acquisition by The First American Corporation of the outstanding minority interests of First Advantage Corporation;
  • Fisher Communications, Inc. in its sale to Sinclair Broadcast Group, Inc;
  • The Talbots, Inc. in its sale to Sycamore Partners, and in its sale of the J. Jill business to Golden Gate Capital; and
  • King Pharmaceuticals, Inc. in its US$1.6 billion unsolicited acquisition of Alpharma Inc.